Granules India intimates of successful USFDA inspection of Gagillapur facility
Located at Hyderabad, Telangana
Granules India announced that Company's Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 17 2016 | 9:24 AM IST